Immunodetection and quantitation of imidazoline receptor proteins in
platelets of patients with major depression and in brains of suicide
victims
by
Garcia-Sevilla JA, Escriba PV, Sastre M, Walzer C,
Busquets X, Jaquet G,
Reis DJ, Guimon J
Department of Psychiatry Medical School,
University of Geneva, Switzerland.
Arch Gen Psychiatry 1996 Sep; 53(9):803-10
ABSTRACT
BACKGROUND: Imidazoline receptors are a newly discovered family of receptors,
some of which, like alpha 2-adrenoceptors, have a presynaptic inhibitory effect
on the release of norepinephrine. The aim of this study was to identify by
immunodetection imidazoline receptor proteins in human platelets and the brain
to assess their status in depression and suicide. METHODS: Platelets were
collected from 26 drug-free depressed patients and 26 controls. Specimens of
frontal cortex (Brodmann area 9) were collected from 13 suicide victims and 11
controls. Levels of imidazoline receptor proteins were assessed by
immunoblotting techniques. Solubilized imidazoline receptors were separated by
gel electrophoresis, transferred to nitrocellulose membranes, labeled with a
specific anti-imidazoline receptor antiserum, and quantitated by image analysis.
RESULTS: Platelet and brain membranes expressed similar 45-kd imidazoline
receptor proteins, and their mean +/- SEM immunoreactivities were found to be
increased in depressed patients (platelets, 40% +/- 5%) and suicide victims
(brain, 51% +/- 14%). Platelets also expressed a 35-kd imidazoline receptor
protein that was also found to be up-regulated in depressed patients (21% +/-
4%). In contrast, brain membranes did not express this 35-kd protein but
revealed a 29/30-kd imidazoline receptor protein that was found to be
down-regulated in suicide victims (19% +/- 3%). In a subset of depressed
patients who underwent antidepressant treatment, a change in the
immunoreactivity of the up-regulated 45-kd platelet imidazoline receptor protein
(-35% +/- 5%), but not of the 35-kd protein, was observed. CONCLUSION: The
results support a role for the newly discovered imidazoline receptors (mainly
the 45-kd receptor expressed in the brain and platelets) in the pathogenesis of
depression.
Idazoxan
Agmatine
Yohimbine
Reboxetine
Mirtazapine
The evolution of suicide
Alpha2 adrenoreceptors
Noradrenaline and mood
Noradrenaline and dopamine
Imidazoline derivatives and MAO-b
Imidazoline receptors and dopamine
Refs
HOME
HedWeb
Cocaine.org
Future Opioids
BLTC Research
Superhappiness?
Paradise-Engineering
The Abolitionist Project
The Hedonistic Imperative
MDMA: Utopian Pharmacology

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family